{"database": "lobbying", "table": "lobbying_activities", "rows": [[1732122, "6a772079-e1e0-4638-98e6-2816aecd8015", "Q3", "CHRISTY ELLERBEE CONSULTING, LLC", 401103332, "INDIVIOR, PLC (FKA RECKITT BENCKISER PHARMACEUTICALS, INC.)", 2015, "third_quarter", "PHA", "H.R. 2872 Opioid Addiction Treatment Modernization Act.\nH.R. 1821 and S. 707 Opioid Overdose Reduction Act of 2015.\nH.R. 2536 and S. 1455 TREAT ACT.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2015-10-15T14:34:29.793000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1732122"], "units": {}, "query_ms": 13.222048990428448, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}